decisionhealth Newsletters, Part B News - 2000 Issue 12 (December)
New billing opportunity for common eye disease
Subscribe or sign in to view the full article.
Article Overview
This article explains a Medicare coverage update involving ocular photodynamic therapy for age-related macular degeneration and related retinal disease considerations. It is aimed at coders, billing staff, ophthalmology practices, and reimbursement professionals who need to understand the policy change, the relevant code sets, and the general scope of the covered and noncovered clinical categories discussed in the source.
Why This Topic Matters
The article matters because it signals a new Medicare payment pathway for a commonly treated eye disease and notes that coverage, separate drug payment, and post-treatment review considerations are changing. Practices that bill ophthalmology services need to recognize the policy context and the code sets referenced in the decision.
What You Will Learn
- The Medicare coverage context for ocular photodynamic therapy in ophthalmology
- How the article frames the relationship between the procedure, the drug, and payment policy
- Which general retinal disease categories are discussed as part of the coverage update
- Why follow-up review and duration considerations are mentioned in the policy discussion
Who Should Read This
- Medical coders
- Billing specialists
- Ophthalmology practices
- Reimbursement managers
- Compliance staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com